Astrana Health (NASDAQ:ASTH) Shares Down 5.3% – Time to Sell?

Shares of Astrana Health, Inc. (NASDAQ:ASTH) fell 5.3% during mid-day trading on Wednesday . The company traded as low as $46.25 and last traded at $46.38. Approximately 57,615 shares changed hands during trading, a decline of 89% from the average session volume of 548,109 shares. The stock had previously closed at $49.00.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on ASTH shares. Robert W. Baird set a $45.00 price target on Astrana Health in a research note on Friday, May 8th. Weiss Ratings upgraded Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 1st. Truist Financial raised their target price on Astrana Health from $38.00 to $47.00 and gave the company a “buy” rating in a report on Thursday, May 14th. TD Cowen boosted their target price on shares of Astrana Health from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Tuesday. Finally, Barclays upgraded shares of Astrana Health from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $37.00 to $50.00 in a research report on Tuesday, May 26th. Seven research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $47.86.

Astrana Health Stock Down 4.1%

The firm has a 50 day moving average of $41.29 and a two-hundred day moving average of $31.15. The stock has a market capitalization of $2.51 billion, a PE ratio of 73.93 and a beta of 0.89. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.20.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Thursday, May 7th. The company reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. The company had revenue of $965.10 million for the quarter, compared to the consensus estimate of $949.21 million. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.Astrana Health’s quarterly revenue was up 55.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.42 earnings per share. Equities research analysts anticipate that Astrana Health, Inc. will post 1.25 earnings per share for the current year.

Institutional Investors Weigh In On Astrana Health

Several institutional investors and hedge funds have recently made changes to their positions in the business. Royal Bank of Canada grew its stake in Astrana Health by 6.5% in the 1st quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock valued at $8,640,000 after acquiring an additional 17,028 shares during the last quarter. AQR Capital Management LLC acquired a new position in Astrana Health during the first quarter worth about $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Astrana Health by 5.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock worth $799,000 after acquiring an additional 1,263 shares during the last quarter. Jones Financial Companies Lllp raised its position in Astrana Health by 4,365.2% during the first quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock worth $346,000 after acquiring an additional 10,913 shares during the last quarter. Finally, Intech Investment Management LLC lifted its holdings in shares of Astrana Health by 5.8% in the first quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock valued at $1,383,000 after purchasing an additional 2,462 shares in the last quarter. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.